Drug-related problems experienced by rheumatoid arthritis patients during the first three months of methotrexate use: a longitudinal observational study
- 3 April 2025
- journal article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 47 (3) , 884-890
Abstract
Methotrexate (MTX) is the cornerstone of rheumatoid arthritis (RA) treatment. However, patients using MTX often experience drug-related problems (DRPs), negatively affecting adherence and persistence. To identify the number and type of DRPs experienced by RA patients during the first 3 months of MTX treatment. A longitudinal observational study was conducted in the Sint Maartenskliniek, The Netherlands, between March and August 2023. Adult RA patients were interviewed at 2, 6 and 12 weeks after MTX initiation using the United Kingdom's New Medicines Service interview guide. DRPs were categorized using a classification system for patient-reported DRPs, and analyzed descriptively. All fifty participants (median age 62 years (IQR 51-68), 66% female) reported a DRP, with a median of 6 (IQR 3-8) DRPs per patient and a total of 301 DRPs. The top 5 most frequently reported DRPs were concerns about (long-term) side-effects, nausea, fatigue, remembering intake and information needs regarding dose instructions. Of the DRPs reported at weeks 2 and 6, 33% were unresolved at week 12. Patients with RA experience numerous DRPs in the first 3 months of MTX use. Resolving DRPs soon after occurrence may reduce the burden of drug treatment and improve adherence and/or persistence.Keywords
This publication has 13 references indexed in Scilit:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateAnnals of the Rheumatic Diseases, 2022
- Drug-related problems in patients with rheumatoid arthritisTherapeutics and Clinical Risk Management, 2019
- Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic ReviewThe Journal of Rheumatology, 2016
- Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized TrialFrontiers in Pharmacology, 2016
- Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine ServiceBMJ Quality & Safety, 2015
- Adherence Rates and Associations with Nonadherence in Patients with Rheumatoid Arthritis Using Disease Modifying Antirheumatic DrugsThe Journal of Rheumatology, 2009
- Treatment of rheumatoid arthritisAmerican Journal of Health-System Pharmacy, 2006
- Comparison of Drug-Related Problems in Different Patient GroupsAnnals of Pharmacotherapy, 2004
- Patients' problems with new medication for chronic conditionsQuality and Safety in Health Care, 2004
- Drug-Related Problems and Quality of Life in Arthritis and Low Back Pain SufferersValue in Health, 2003